Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3298414018 | Parenteral form bevacizumab (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3298581018 | Parenteral form bevacizumab | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488570016 | Product containing bevacizumab in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497622016 | Bevacizumab in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497623014 | Product containing bevacizumab in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3708804013 | Product containing bevacizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3708805014 | Bevacizumab-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bevacizumab-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Bevacizumab-containing product in parenteral dose form | Is a | Bevacizumab-containing product | true | Inferred relationship | Some | ||
| Bevacizumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Bevacizumab-containing product in parenteral dose form | Has active ingredient | Bevacizumab | true | Inferred relationship | Some | 1 | |
| Bevacizumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bevacizumab only product in parenteral dose form | Is a | True | Bevacizumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Bevacizumab 25mg/mL injection solution 4mL vial | Is a | False | Bevacizumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Bevacizumab 25mg/mL injection solution 16mL vial | Is a | False | Bevacizumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Bevacizumab 400 mg/16 mL solution for injection vial | Is a | False | Bevacizumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Bevacizumab 100 mg/4 mL solution for injection vial | Is a | False | Bevacizumab-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR